This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1995 Aug 26;346(8974):581-2.

doi: 10.1016/s0140-6736(95)91422-6.

Treatment regimens in Gaucher's disease

PMID: 7658807
DOI: 10.1016/s0140-6736(95)91422-6

Comment

Treatment regimens in Gaucher's disease

E Beutler. Lancet. 1995.

. 1995 Aug 26;346(8974):581-2.

doi: 10.1016/s0140-6736(95)91422-6.

Author

PMID: 7658807
DOI: 10.1016/s0140-6736(95)91422-6

No abstract available

PubMed Disclaimer

Comment on

Individualised low-dose alglucerase therapy for type 1 Gaucher's disease.
Hollak CE, Aerts JM, Goudsmit R, Phoa SS, Ek M, van Weely S, von dem Borne AE, van Oers MH. Hollak CE, et al. Lancet. 1995 Jun 10;345(8963):1474-8. doi: 10.1016/s0140-6736(95)91037-9. Lancet. 1995. PMID: 7769902 Clinical Trial.
Replacement therapy with imiglucerase for type 1 Gaucher's disease.
Zimran A, Elstein D, Levy-Lahad E, Zevin S, Hadas-Halpern I, Bar-Ziv Y, Foldes J, Schwartz AJ, Abrahamov A. Zimran A, et al. Lancet. 1995 Jun 10;345(8963):1479-80. doi: 10.1016/s0140-6736(95)91038-7. Lancet. 1995. PMID: 7769903 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- Genetic Alliance
- MedlinePlus Health Information